Stephane Bello
Analyst · Morgan Stanley
Thank you, Jim, and good morning or good afternoon to you all. As usual, I will speak to revenue growth before currency throughout today's presentation. These slides provide a snapshot of our third quarter and 9 months results, which do reflect the impact of the charges which we flagged earlier this year. These charges had an $18 million impact at the EBITDA level for the third quarter and a $58 million impact for the first 9 months. For the comparable periods last year, we incurred charges of $10 million and $97 million, respectively. We still expect charges for the full year to total $120 million with about $60 million having being incurred through September. This effectively means that we expect to incur an additional $60 million in the fourth quarter, primarily within our Financial & Risk business. Our third quarter revenues were up 1% with flat organic revenue growth, and this is in line with our guidance for the full year. Our Financial & Risk segment declined 2% and was down 3% organically while our other businesses grew 4% in aggregate during the third quarter and were up 3% organically. Adjusted EBITDA was down 3% with an EBITDA margin of 26.5%, down 100 basis points from the prior year period. Excluding charges from both periods, the EBITDA margin was 27% in the third quarter compared to 27.8% last year. As Jim just indicated, foreign exchange had a higher-than-usual impact on the EBITDA margin this quarter. Excluding the impact of currency and the charges from both periods, the consolidated EBITDA margin was down 10 basis points compared to Q3 last year. Finally, underlying operating profit in Q3 declined 3% with the margin down 70 basis points. Excluding currency and charges, the consolidated margin was up 20 basis points year-over-year. We continue to expect margins for the full year to be within the guidance we provided you last February. Now let me provide you with some additional color on the performance of our individual businesses, starting with Legal. Demand for legal services in the U.S. market, as measured by Peer Monitor, improved over the second quarter and marks the strongest quarter since Q4 2012. Transactional practice areas continued to show improvement. However, demand for litigation, which is the largest practice area in the U.S. from a revenue perspective, remained below historical averages. During the quarter, Legal grew 1%, all organic, and this marked the return to organic revenue growth for the first time since the second quarter of 2013. As expected, U.S. print revenues continued to be a drag on revenue growth, declining 8%. Excluding the impact of U.S. print, revenues rose 3% organically. I'll get back on this in a moment. Transactional revenues, which represent 12% of the total, were up 1% and were flat organically. Subscription revenues, which accounted for about 75% of the total, were up 4% and 3% organic. The continued strong organic performance of our subscription revenues during the quarter is a good indicator of the underlying strength of the business. Turning to our profitability metrics. The EBITDA margin was down 10 basis points while the operating profit margin increased 30 basis points. So the Legal business continues to do an excellent job of maintaining margins against the backdrop of declining U.S. print revenues, which as we have said in the past, makes up for a challenging revenue mix. Now as you can see on this slide, the underlying trends in the Legal business are encouraging. As a reminder, U.S. print revenues represent about 15% of total Legal revenues. So the graph on this slide shows the gross trend for the remaining 85% of Legal's revenue base. As I just mentioned, Legal's total revenue growth was 1%. However, when we strip out U.S. print revenues, you can clearly see the improving trends in the business on this slide. The remaining 85% from the Legal revenue base has improved sequentially over the past 4 quarters with a 400 basis points improvement over the last 12 months. Here's a more detailed look at the revenue performance of the 3 main subsegments in our Legal business. This graph provides a good depiction of the changing revenue mix dynamics as our solution businesses become an increasingly larger proportion of Legal's total revenue base. As a reminder, these solution businesses consist of everything except U.S. online legal information and U.S. print. In aggregate, they made up 47% of Legal's total revenues in the third quarter, up from 45% last year. And they grew 7%, 6% organically, driven by strong growth in Elite, Pangea3 and Practical Law. U.S. print revenues were down 8%, as mentioned earlier. And finally, U.S. online legal information, which is 38% of total revenues, declined 1%. We had seen a gradual improvement in this business since the beginning of the year, and we are encouraged by the slowly improving trajectory. Our Tax & Accounting business continued to build on its momentum and is having a strong year. Revenues for Q3 grew 13%, of which 9% was organic. Recurring revenues, about 85% of the total, grew 8% organically. From a profitability standpoint, EBITDA grew 9% in the quarter while the margin declined 50 basis points due to organic investments we are making in what is our highest-growth business. As for the 9-month period, the EBITDA margin increased 60 basis points. During the third quarter, operating profit was up 26% with the margin up 170 basis points, reflecting the impact of lower acquisition-related amortization expenses. Full year margins are more reflective of the segment's underlying performance and small movements in the timing of revenues and expenses can impact margins in any given quarter. And as you can see on this slide, we achieved strong growth in most segments of our Tax & Accounting business during the quarter. In particular, both the corporate and professional segments delivered organic revenue growth of 11%. Knowledge Solutions was up 4% and 2% organically, and government revenues were up 8%. IP & Science revenues were up 3%, all organic. This performance was driven by growth across all business segments, with Life Sciences displaying the strongest performance, up 6% and 5% organically. EBITDA was down 5% and operating profit declined 11% due to the impact of negative revenue mix as well as some investments we are making in the IP & Science business. Similar to our Tax & Accounting business, full year margins are more reflective of this segment's underlying performance because small movements in the timing of revenues and expenses, again, can impact margins in any given quarter. During the third quarter, recurring revenues for IP & Science represented about 3/4 of their total revenues and grew 5%, all organic. And transaction revenues in the third quarter were down 4%. Now turning to the third quarter results for our Financial & Risk business. Revenues were down 2% with a 1% contribution from acquisitions, so organic revenues were down 3%. This organic revenue decline reflected the continued impact of our aggregate negative net sales performance over the prior 12 months, with Q4 of last year having a disproportionate impact on that period. As Jim discussed earlier, net sales were positive in the third quarter and are positive year-to-date. It is too early to say whether net sales will be positive for the full year, but we expect the trend of year-on-year improvement to continue in Q4 as it has in 7 of the last 8 quarters. Now let me remind you that net sales primarily measures the impact of volume on future revenues. And as Jim mentioned, we recently began migrating our remaining legacy buy side and foreign exchange products to our unified platform, which may lead to lower price realization for some customers. This is likely to dampen the overall benefit we would normally expect to realize from our annual price increase. However, we anticipate that the improving trends in net sales and greater price discipline will partly mitigate this impact and will contribute to a year-on-year improvement in the top line growth performance of our Financial business in 2015. The EBITDA margin was down 130 basis points with charges of $18 million this quarter versus $5 million last year. Excluding charges from both periods, the EBITDA and operating profit margins were each down 50 basis points versus Q3 of last year. Now foreign exchange had a significant negative impact on the F&R EBITDA margin this quarter due to our very large cost base in the U.K. and the strengthening of the pound. Excluding the impact of foreign exchange and the $18 million of charges incurred during the quarter, the EBITDA margin would have been 27.1%, which would represent an improvement of 100 basis points over Q3 2013. Now looking at Financial & Risk revenue in a bit more detail. Recurring revenues, which were 76% of the total, declined 3% during the quarter, and this decline was the result of the negative net sales in the prior 12 months. Recoveries, about 11% of the total, were up 1% for the quarter. And let me remind you that recoveries are low-margin revenues. Transaction revenues, which is 13% of the total, increased 3%, but were down 5% on an organic basis. So this is the third consecutive quarter of negative growth in F&R's transactions business this year. This is due to the low level of volatility we had seen in the markets until very recently. For the first 9 months of the year, transaction revenues were down 6% organically. Since transaction revenues are highly profitable, this is obviously hurting F&R's margin performance, which would have been better had transaction revenues been more stable as was the case in prior years. The silver lining is that we did see a rebound in transaction volumes in the last 10 days of the quarter. As we said before, we do need to see some improvement in the transaction revenues in order for F&R to return to positive growth next year, and the fourth quarter will be an important indicator in that regard. Looking at revenues for the third quarter by geography. Europe, Middle East and Africa, which is F&R's largest geographic segment, was down 4%, reflecting the continued impact of last year's negative net sales. Revenues in the Americas were flat and down 3% organic due to the net sales flow-through as well as the impact of low fixed-income transaction volumes, which predominantly affect this region. And revenues in Asia were flat and down 1% organically. Once again, this reflected the 2013 net sales flow-through, offsetting the revenue impact of the positive sales we had seen in the region for the first 3 quarters of the year. Now let me turn to the review of our consolidated results. Third quarter adjusted EPS was $0.45 per share, $0.03 lower than a year ago. The $0.03 decrease was attributable to lower operating profit and a higher tax rate, 15% this year versus 11% last year. Foreign currency and the higher tax rate each added $0.02 negative impact on EPS in the quarter as compared to the prior year period. For the full year, we remain comfortable with our guidance for interest expense of between $450 million and $475 million as well as an effective tax rate of between 13% and 15%. Now turning to our free cash flow performance for the first 9 months of the year, and working from the bottom to the top of this slide. Free cash flow for the first 9 months of the year was $875 million. This included $212 million of simplification costs as well as a decrease of $75 million of cash flow related to disposals. As such, ongoing free cash flow, excluding the impact of disposals, was down 3% during the first 9 months of the year. And finally, ongoing free cash flow, excluding the impact of simplification charges, was about $1.1 billion or $59 million higher than the prior year period, which represented a 6% increase. So to wrap up, we are pleased with our year-to-date financial results. And based on these results, we are reaffirming our outlook for the full year, which is summarized on this slide. With that, let me now turn it back over to Frank.